title: Is aspirin still the antiplatelet drug of choice for patients with peripheral arterial disease?
authors.forename: M I
authors.initials: MI
authors.lastname: Matsagas
authors.forename: I A
authors.initials: IA
authors.lastname: Jagroop
authors.forename: D P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: G
authors.initials: G
authors.lastname: Geroulakos
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D006801:Humans; D016491:Peripheral Vascular Diseases / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin